The Fallopian tube odyssey: From the ovary to the tube. about high-grade serous ovarian carcinoma;L'odyssée de la trompe de Fallope: de l'ovaire à la trompe. À propos du cancer séreux de haut grade de l'ovaire

Bulletin du Cancer

Volumn 100, Issue 7-8, 2013, Pages 757-764

  Chêne, Gautier ^a,b   Dauplat, Jacques ^a   Radosevic Robin, Nina ^a   Cayre, Anne ^a   Penault Llorca, Frédérique ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Fallopian tube; Ovarian cancer; Ovarian carcinogenesis; Ovarian dysplasia; P53; STIC

Indexed keywords

ARTICLE; CANCER SCREENING; CARCINOGENESIS; OVARIAN EPITHELIAL DYSPLASIA; OVARIAN SEROUS CARCINOMA; OVARY CARCINOMA; PRECANCER; UTERINE TUBE;

FALLOPIAN TUBE; OVARIAN CANCER; OVARIAN CARCINOGENESIS; OVARIAN DYSPLASIA; P53; STIC;

CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; HUMANS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 84882931909     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2013.1785     Document Type: Article

References (30)

1. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the Fallopian tube: a descriptive classification. Int J Gynecol Pathol 2008;27: 1-9.
2. Chêne G, Dauplat J, Bignon YJ, et al. Ovarian carcinogenesis: recent and old hypothesis. Gynecol Obstet Fertil 2011;39: 216-23.
3. Ming-Shih I, Kurman RJ. Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004; 164: 1511-8.
4. Lowery WJ, Schildkraut JM, Akushevich L, et al. Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers. Int J Gynecol Cancer 2012; 22: 9-14.
5. Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 2012; 460:237-49.
6. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474:609-15.
7. Fathalla M. Incessant ovulation: a factor in ovarian neoplasia? Lancet 1971; 2: 163.
8. Riman T, Nilsson S, Persson IR. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 2004;83: 783-95.
9. Gusberg SB, Deligdisch L. Ovarian dysplasia, a study of identical twins. Cancer 1984;54:1-4.
10. Chêne G, Penault-Llorca F, Le Bouedec G, et al. Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk. Int J Gynecol Cancer 2009;19:65-72.
11. Deligdisch L, Einstein AJ, Guera D, Gil J. Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks. Cancer 1995;76:1027-34.
12. Nieto JJ, Crow J, Sundaresan M, et al. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. Gynecol Oncol 2001;82: 344-9.
13. Chêne G, Penault-Llorca F, Le Bouedec G, et al. Ovarian epithelial dysplasia after ovulation induction: time and dose effect. Hum Reprod 2009; 24:132-8.
14. Dauplat J, Chêne G, Pomel C, et al. Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer. Eur J Cancer 2009;45: 2977-83.
15. Piek JM, van Diest PJ, Zweemer RP. Dysplastic changes in prophylactic removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001;195: 451-6.
16. Mehrad M, Ning G, Chen EY, Mehra KK, Crum CP. A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the Fallopian tube. Adv Anat Pathol 2010;17: 293-302.
17. Kuhn E, Kurman RJ, Soslow RA, et al. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma. Am J Surg Pathol 2012; 36:1826-34.
18. Rabban JT, Krasik E, Chen LM, et al. Multistep level sections to detect occult Fallopian tube carcinomas in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol 2009;33: 1878-85.
19. Kuhn E, Kurman RJ, Vang R, et al. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions. J Pathol 2012;226: 421-6.
20. Sehdev AS, Kurman RJ, Kuhn E, et al. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including RSF-1 (HBXAP), cyclin E and fatty acid syn-thase. Mod Pathol 2010;23:844-55.
21. Karst AM, Levanon K, Duraisamy S, et al. Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecol Oncol 2011;123: 5-12.
22. Kuhn E, Meeker A, Wang TL, et al. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol 2010; 34: 829-36.
23. Karst AM, Levanon K, Drapkin R. Modeling high-grade serous ovarian carcinogenesis from the Fallopian tube. PNAS 2011; 108: 7547-52.
24. Schlosshauer PW, Cohen CJ, Penault-Llorca F, et al. Prophylactic oophorectomy. Cancer 2003;98:2599-606.
25. King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, Burdette JE. The impact of ovulation on Fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer 2011;18: 627-42.
26. Cibula D, Widschwendter M, Majek O, Dusek L. Tubal liga-tion and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update 2011; 17: 55-67.
27. Collins IM, Domchek SM, Huntsman DG, et al. The tubal hypothesis of ovarian cancer: caution needed. Lancet Oncol 2011;12: 1089-91.
28. Parker WH. Bilateral oophorectomy versus ovarian conservation: effects on long-term women's heath. J Minim Invasive Gynecol 2010;17: 161-6.
29. Jacobs I, Menon U. Can ovarian cancer screening save lives? The question remains unanswered. Obstet Gynecol 2011; 118: 1209-11.
30. McAlpine JN, El Hallani S, Lam SF, et al. Autofluorescence imaging can identify preinvasive or clinically occult lesions in Fallopian tube epithelium: a promising step towards screening and early detection. Gynecol Oncol 2011;120:385-92.